Sara Marrero-Hernández

Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial

D. Purcell, K. Subbarao, Thi H. O. Nguyen, 2021, The Lancet Infectious Diseases.

Altered expression of the tachykinins substance P/neurokinin A/hemokinin-1 and their preferred neurokinin 1/neurokinin 2 receptors in uterine leiomyomata.

F. Pinto, T. Almeida, D. Báez, 2016, Fertility and sterility.